Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects
Clinical trial NCT04483375 · COMPLETED
Trial details
- NCT number
- NCT04483375
- Sponsor
- Sinocelltech Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-24
- Primary completion
- 2020-11-17
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.